Papers
1
Total Citations
2
H-Index
1
About
Dr. Kunhan Dai is a clinician-researcher specializing in hereditary renal cancer syndromes, with a particular focus on HLRCC-associated renal cell carcinoma (RCC). His work addresses the critical intersection of genetic predisposition, surgical management, and reproductive health in patients with rare kidney cancers. Dr. Dai’s most cited publication, a 2022 case report, documents the first known instance of a patient with bilateral HLRCC-associated RCC successfully undergoing two partial nephrectomies and subsequently achieving a safe pregnancy. This contribution is significant for its practical guidance on fertility preservation and oncological safety in young patients with hereditary cancer syndromes. Though early in his career, with 2 citations on this landmark case, his work fills a vital gap in the literature, offering hope and clinical direction for managing complex, life-altering diagnoses. Dr. Dai’s research underscores the importance of personalized, multidisciplinary care for rare genetic conditions, and his case report serves as a foundational reference for oncologists, urologists, and genetic counselors navigating similar high-stakes scenarios.
Research Focus
Key Achievements
Top Papers
- 1